Clinical trial
C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary…
NCT00289211 · Shire, Industry · Completed
Key facts
| NCT number | NCT00289211 |
|---|---|
| Title | C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks |
| Official title | LEVP2005-1/Part A: A Double-blind, Placebo-Controlled, Clinical Study to Investigate the Efficacy and Safety of Purified C1 Esterase Inhibitor (Human) for the Treatment of HAE in Acute Attacks |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hereditary Angioedema |
| Intervention type | Biological, Drug |
| Interventions | C1 esterase inhibitor [human] (C1INH-nf), Placebo (saline) |
| Enrollment | 83 |
| Start date | Mar 14, 2005 |
| Primary completion | Apr 13, 2007 |
| Completion | Apr 13, 2007 |
| First posted | Feb 9, 2006 |
| Last update posted | Jun 11, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: